Literature DB >> 19372094

Neurological outcome in preterm small for gestational age infants compared to appropriate for gestational age preterm at the age of 18 months: a prospective study.

Paraskevi Karagianni1, Maria Kyriakidou, Georgios Mitsiakos, Helias Chatzioanidis, Emmanouel Koumbaras, Athanasios Evangeliou, Nikolaos Nikolaides.   

Abstract

The aim of this study was to investigate the neurological outcome of premature small for gestational age infants at the corrected age of 18 months by the Hammersmith Infant Neurological Examination. A prospective trial was conducted comparing 41 preterm infants being small for gestational age with 41 appropriate for gestational age infants. Birth weight was significantly lower in small for gestational age infants compared with appropriate for gestational age infants (1724.6 +/- 433 versus 1221 +/- 328 g). There were no significant differences regarding the median gestational age and Apgar scores. Median global scores differ significantly between both groups: 75 (47-78) versus 76 (72-78) for the small for gestational age and appropriate for gestational age infants, respectively. Both groups had optimal scores. In conclusion, although the small for gestational age group scored lower in the Hammersmith Infant Neurological Examination, median global score in both groups was within optimal range.

Entities:  

Mesh:

Year:  2009        PMID: 19372094     DOI: 10.1177/0883073809333538

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Implementation of the Hammersmith Infant Neurological Examination in a High-Risk Infant Follow-Up Program.

Authors:  Nathalie L Maitre; Olena Chorna; Domenico M Romeo; Andrea Guzzetta
Journal:  Pediatr Neurol       Date:  2016-09-21       Impact factor: 3.372

2.  Risk factors and complications of small for gestational age.

Authors:  Qiang Liu; Hui Yang; Xuemei Sun; Guimei Li
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.